Kasia Adamczuk

ORCID: 0009-0009-5158-6818
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Lung Cancer Treatments and Mutations
  • Acute Ischemic Stroke Management
  • Atrial Fibrillation Management and Outcomes
  • Intracranial Aneurysms: Treatment and Complications
  • Cancer Genomics and Diagnostics
  • Esophageal Cancer Research and Treatment
  • Neurofibromatosis and Schwannoma Cases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Vascular Malformations Diagnosis and Treatment
  • Neurosurgical Procedures and Complications

University of Edinburgh
2015-2025

Campbell Collaboration
2021

10.1038/ng.3357 article EN Nature Genetics 2015-07-20
Rustam Al‐Shahi Salman Martin Dennis Peter Sandercock Cathie Sudlow Joanna M. Wardlaw and 95 more William Whiteley Gordon Murray Jacqueline Stephen Aryelly Rodríguez Steff Lewis David J. Werring Phil White Colin Baigent Daniel Lasserson Frank Sullivan Johanna Carrie David E. Newby Nikola Sprigg Javier Rojas Bernadette Gallagher Elizabeth Brownsell Paul Dearie Alice Graves Louisa Wilson Gelnna Hamer Elizabeth A. Craig Priscilla Sauramba Nicola Lyttle Shannon Amoils John Bamford Jane Armitage Gabriël J.E. Rinkel Gordon Lowe Jonathan Emberson Karen Innes Lynn Dinsmore Jonathan Drever Carol Williams David Perry Connor McGill David L. Buchanan Allan Walker Aidan Hutchison Christopher R. Matthews Ruth Fraser Aileen McGrath Ann Deary Rosemary Anderson Pauli Walker Kasia Adamczuk Christian Holm Hansen Richard Parker Robert J Lee Malcolm Macleod Thomas Moullaali Jeb Palmer Eleni Sakka Jennifer Adil-Smith David Minks Dipayan Mitra Priya Bhatnagar Johan du Plessis Yogish Joshi Kelly Stewart Kate Covil Mark Rodrigues Christine Lerpiniere Richard O’Brien Seona Burgess Gillian Mead Ruth Paulton Fergus Doubal Katrina McCormick Neil Hunter Pat Taylor Ruwan Parakramawansha Jack Perry Gordon W. Blair Allan MacRaild Adrian Parry‐Jones Mary Johnes Stephanie J. Lee Kelly Marie Shaw Ilse Burger Martin Punter Andrea Ingham Jane Perez Zin Naing Jordi Morell Tracy Marsden Andrea C. Hall Sally J. Marshall Louise Harrison R. Jarapa Edith Wood V. O'Loughlin David Cohen Silvie Davies Kelechi Njoku Mushiya Mpelembue

<h3>Importance</h3> The Restart or Stop Antithrombotics Randomized Trial (RESTART) found that antiplatelet therapy appeared to be safe up 5 years after intracerebral hemorrhage (ICH) had occurred during antithrombotic (antiplatelet anticoagulant) therapy. <h3>Objectives</h3> To monitor adherence, increase duration of follow-up, and improve precision estimates the effects on recurrent ICH major vascular events. <h3>Design, Setting Participants</h3> From May 22, 2013, through 31, 2018, this...

10.1001/jamaneurol.2021.2956 article EN cc-by JAMA Neurology 2021-09-03

Background Symptomatic cerebral cavernous malformations are a rare sporadic or familial disease, which may cause haemorrhagic strokes epileptic seizures. In 2015, James Lind Alliance Priority Setting Partnership ranked targeted drug therapies as fourth of the top 10 research priorities for malformations. There no disease-modifying drugs malformations, but there several promising candidates with proof concept in human and animal studies. platform trials Objectives (1) Consolidate initiate...

10.3310/tyup6982 article EN publisher-specific-oa Efficacy and Mechanism Evaluation 2025-03-01

Primary research question For adults surviving spontaneous (non-traumatic) symptomatic intracranial haemorrhage with persistent/paroxysmal atrial fibrillation/flutter (AF), does starting full treatment dose oral anticoagulation (OAC) result in a beneficial net reduction of all serious vascular events compared not OAC? Trial design Investigator-led, multicentre, randomised, open, assessor-masked, parallel group, clinical trial investigational medicinal product (CTIMP) prescribing strategies....

10.17504/protocols.io.bcw4ixgw preprint EN 2020-02-25
Coming Soon ...